Illuccix Telix

Inside Telix: The Aussie guided nuclear missile for cancer

Innovation

Radio-pharma biotech Telix is building on the success – and the cashflow – from its nuclear-guided prostate cancer tool to aim for new cancers, and new treatments.
Telix
Telix CEO and cofounder Christian Behrenbruch

Christian Behrenbruch was outraged. That’s what started it all. The then 26-year-old PhD candidate from Melbourne was at a routine lab meeting at Oxford when it was mentioned that the lab was dropping a bunch of patents it owned. 

Subscribe to Forbes Australia for full access to this and all articles today

Subscribe     Already a subscriber? Sign In